Navigation Links
Doubling Tamiflu Dose for Severe Flu Doesn't Help: Study
Date:5/31/2013

THURSDAY, May 30 (HealthDay News) -- People with a severe case of the flu don't benefit from taking double doses of the antiviral drug Tamiflu, according to a new study conducted in Southeast Asia.

Tamiflu (oseltamivir) stocks could be conserved during pandemics if doctors prescribe only standard doses of this medication, World Health Organization experts suggested.

The study involved 326 patients diagnosed with severe flu at 13 hospitals in Indonesia, Singapore, Thailand and Vietnam between April 2007 and February 2010. Most of the patients were children younger than 15, but some adults also were included.

Health-care workers treated the patients with either a standard dose of Tamiflu (75 milligrams twice daily or the children's equivalent), or a double dose of the medication (150 milligrams twice daily or children's equivalent) over the course of five days.

Patients' virus levels were measured through nose and throat swabs. Researchers then tracked how many patients died, were admitted to the intensive care unit or required the help of a ventilator to breath.

After five days of treatment, there were no differences between the patients on a standard dose of Tamiflu and those given the double dose. Moreover, no differences were seen in death rates or other adverse events, the study found.

The findings were published online May 30 in the journal BMJ.

The study authors concluded that there's no added benefit from a higher dose of Tamiflu to treat severe flu, according to a journal news release.

In an accompanying editorial, Ian Barr and Aeron Hurt from the WHO Collaborating Centre for Reference and Research on Influenza, wrote that a double dose of Tamiflu "is unlikely to significantly improve the clinical outcomes of severe cases of seasonal influenza."

They added that the study's findings "could help to preserve oseltamivir (Tamiflu) stocks during a future pandemic if clinicians were to prescribe only regular rather than double doses." They noted, however, that flu treatment options must be expanded and further research is needed on more effective combinations of drugs.

More information

The U.S. Centers for Disease Control and Prevention has more about flu drugs.

-- Mary Elizabeth Dallas

SOURCE: BMJ, news release, May 30, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Doubling Up on Cold, Flu Remedies May Harm Liver
2. Doubling down against diabetes
3. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
4. New China Bird Flu May Be Resistant to Tamiflu
5. Spot Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
6. Flu Drug Tamiflu OK for Babies Under 1: FDA
7. Release all Tamiflu data as promised, argue researchers
8. Vaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of Iowa Woman Who Sustained Severe, Permanent Injuries Allegedly Due to Defective Ethicon Bladder Mesh
9. Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats
10. Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups
11. New Treatment for Severe Asthma Introduced at St. Elizabeth Health Center
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Doubling Tamiflu Dose for Severe Flu Doesn't Help: Study
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: